Brief: Vyant Bio Reports Third Quarter 2021 Results And Provides Strategic Business Updates
11/11/2021 21:02
Nov 11 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO REPORTS THIRD QUARTER 2021 RESULTS AND PROVIDES
STRATEGIC BUSINESS UPDATES
* Q3 REVENUE $1.5 MILLION
* QTRLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nGNX3n5487
Further company coverage: VYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration